Synaptogenix

Synaptogenix reports disappointing data from Phase II Alzheimer’s trial
Clinical Trials Arena
Mon, 12/19/22 - 11:08 am
Synaptogenix
clinical trials
NIH
Alzheimer's disease
Bryostatin-1